Drug factory · FDA FEI 3003131673

Novo Nordisk A/S - 25a-B

Brennum Park 25A, Hilleroed, Denmark

Denmark: 1

Problems found, fixed voluntarily at FDA's last inspection, Sep 17, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2012: 1 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
SemaglutideMakes it Novo Nordisk 0169-4915

FDA inspection history

EndedResultProgramProblems noted
Sep 17, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 4, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 14, 2018Problems found, fixed voluntarilyDrug Quality Assurance—
Oct 10, 2014No problems foundDrug Quality Assurance—
Mar 21, 2012Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture; label; manufacture; pack.